Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • GST may lead to drug...

    GST may lead to drug shortage; chemists not keeping stock: Kiran Mazumdar-Shaw, Biocon

    Written by Ruby Khatun Khatun Published On 2017-07-02T09:36:30+05:30  |  Updated On 2 July 2017 9:36 AM IST
    GST may lead to drug shortage; chemists not keeping stock: Kiran Mazumdar-Shaw, Biocon

    New Delhi: Biotech major Biocon Chairman and Managing Director Kiran Mazumdar-Shaw today cautioned of possible drug shortage after implementation of GST saying unprepared stockists in the supply chain are refusing to stock medicines.


    She said in the run up to the GST, pharmaceutical firms have taken a huge hit on their businesses in June as a result of pharmacists declining to keep stock.

    "Our stockists are refusing to stock, the supply chain is also not willing to accept material," Mazumdar-Shaw told television channel CNBCTV18.

    Commenting on the possible fallout, she said: "I think bigger impact is the drug shortage that patients are going to face and then we are going to have huge impact on price of drug."

    In case of shortage, Mazumdar-Shaw said there is going to be black marketing of drugs and it is a worrying sign.

    "Pharmacies are not willing to stock medicines...many of them said they are not prepared for GST that is very scary," she said.

    While the companies are prepared but the rest of the supply chain is not prepared, she said adding there were very nervous and worrying signs from pharmacists, stockists and pharma supply chain.

    "They are not even prepared of their IT backbone and required IT capability to deal with GST. Lot of them are saying that formalities involved are so complex that they are really worried whether they can cope with it," she said.

    As a result of the pharmacists refusing to keep stocks, she said: "We have seen huge impact on our business this month. Our businesses have dropped by more than half for this month."

    While Biocon's business is very small in domestic market but those pharma companies which are totally dependent on domestic market are seriously impacted, Mazumdar-Shaw said.

    She lashed out at the GST in its current form saying it has been made into a multiple and complex tax regime and criticised the GST panel for doing "a suboptimal job of delivering a game changing GST regime".
    BioconChemistsdrug pricedrug shortageGSTGST panelKiran Mazumdar ShawmedicinesPharmacistspricestockistssupply chain
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok